Evaluation of Integrating Self Blood Pressure Monitoring Into Urban Primary Care Practices

NCT01123577 | Completed

• 1 other identifier: PCIP-CVD-ESBPM2010
• Study Type: interventional
• Target: 899
• Locations: 1 country
• Sites: 4

Brief Summary

Background: Hypertension (HTN) is a major risk factor for cardiovascular disease (CVD), the leading cause of death in the United States and New York City (NYC). One in 4 NYC adults has hypertension, with higher prevalence in both Blacks and Latinos compared to Whites (Angell 2008). In NYC, only 65% of all adults with HTN and on treatment are controlled (Angell 2008). Self-blood pressure monitoring (SBPM) is associated with reduced blood pressure in patients with hypertension (Cappuccio 2004). Studies suggest that SBPM may increase control either by inducing clinicians to titrate medication more actively, (Agency for Healthcare Research and Quality 2002) by engaging patients to participate in their own health care, (Taylor 2007) or a combination of the two. However, minimal research has been done to evaluate the effectiveness of SBPM in different racial and/or ethnic groups or in low income populations or to discern effective patterns of SBPM use by patients. Best practices for integration of self monitoring into HTN into regular treatment have also yet to be established. Objectives: The goal of this study is to assess the impact of SBPM under conditions consistent with existing community health clinic resources and infrastructure in NYC's medically underserved neighborhoods using commonly available automated home BP monitors. By using a community clinic's electronic health record (EHR) and automated BP monitors with the capability to transmit readings to a research database, we can facilitate a more rigorous evaluation of a pilot SBPM intervention and assess patterns of home monitor use and clinical management and their association with outcomes. The three specific aims of this intervention are to:

1. 1.Assess whether use of SBPM reduces elevated BP and increases HTN control to similar levels in two historically understudied minority populations, Blacks and Latinos.
2. 2.Confirm pilot findings by assessing the impact of SBPM on BP and HTN control compared to usual care using randomized controlled trial methodology.
3. 3.Develop standards and refine guidance for the effective use of SBPM that can be easily communicated to key stakeholders.

Conditions

Hypertension; Cardiovascular Disease

Keywords

Self Blood Pressure Monitoring; SBPM; Randomized Control Trial; Hypertension (HTN); Cardiovascular Disease (CVD); HTN; CVD

Outcome Measures

Primary Outcomes (3)

• Absolute and relative changes in systolic and diastolic BP in the intervention and control groups.

  9 months

• Proportion of intervention participants achieving BP control compared to control participants

  9 months

• Trajectory of BP changes over time.

  9 months

Study Arms (2)

Intervention

EXPERIMENTAL

Other: Home Blood Pressure Monitor Group

Control

NO INTERVENTION

Participants receive usual care by providers.

Interventions

Home Blood Pressure Monitor Group OTHER

Participants receive home monitors, modems, educational materials and training. Participants will send home BP readings to research database monthly and receive usual care by providers for 9 months.

Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adult patients attending one of the participating primary care clinics
• Diagnosis of hypertension for at least 6 months
• Ethnicity or Race of Latino, Black or White
• Physically and mentally able to monitor BP at home
• \*Uncontrolled BP at last office visit
• \*Uncontrolled BP at current office visit
• Note: \*Uncontrolled BP is defined as systolic BP ≥ 140 and/or diastolic BP ≥ 90, or systolic BP ≥ 130 and/or diastolic BP ≥ 80 mm Hg for participants with chronic kidney disease or diabetes.

You may not qualify if:

• Arm circumference greater than 17.5 inches (maximum size of large BP cuff)
• Already monitoring BP at home at request of health care provider
• No access to a land line telephone line (to upload home readings)

Sponsors & Collaborators

• New York City Department of Health and Mental Hygiene: lead
• Robert Wood Johnson Foundation: collaborator
• NYU Langone Health: collaborator
• Riverdale Family Practice, New York City: collaborator
• Heritage Health Center (HHHNYC), New York City: collaborator

Study Sites (4)

Lutheran Family Health Centers

Brooklyn, New York, 11220, United States

Location

New York City Department of Health and Mental Hygiene

New York, New York, 10029, United States

Location

Heritage Health Care

New York, New York, 10031, United States

Location

Riverdale Family Practice

The Bronx, New York, 10463, United States

Location

Related Publications (5)

• Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004 Jul 17;329(7458):145. doi: 10.1136/bmj.38121.684410.AE. Epub 2004 Jun 11.

  PMID: 15194600 BACKGROUND

• Angell SY, Garg RK, Gwynn RC, Bash L, Thorpe LE, Frieden TR. Prevalence, awareness, treatment, and predictors of control of hypertension in New York City. Circ Cardiovasc Qual Outcomes. 2008 Sep;1(1):46-53. doi: 10.1161/CIRCOUTCOMES.108.791954.

  PMID: 20031787 BACKGROUND

• Taylor JR, Campbell KM. Home monitoring of glucose and blood pressure. Am Fam Physician. 2007 Jul 15;76(2):255-60.

  PMID: 17695570 BACKGROUND

• Agency for Healthcare Research and Quality. Utility of Blood Pressure Monitoring Outside the Clinic Setting: Agency for Healthcare Research and Quality; 2002.

  BACKGROUND

• Yi SS, Tabaei BP, Angell SY, Rapin A, Buck MD, Pagano WG, Maselli FJ, Simmons A, Chamany S. Self-blood pressure monitoring in an urban, ethnically diverse population: a randomized clinical trial utilizing the electronic health record. Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2):138-45. doi: 10.1161/CIRCOUTCOMES.114.000950. Epub 2015 Mar 3.

  PMID: 25737487 DERIVED

MeSH Terms

Conditions

Hypertension; Cardiovascular Diseases

Condition Hierarchy (Ancestors)

Vascular Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 12, 2010
• First Posted: May 14, 2010
• Study Start: May 1, 2010
• Primary Completion: July 1, 2012
• Study Completion: August 1, 2012
• Last Updated: August 14, 2012

Record last verified: 2012-08

Locations

US (4)